References
- Laurberg G, Geiger JM, Hjorth N, et al. Treatment of lichen planus with acitretin. A double-blind, placebo-controlled study in 65 patients. J Am Acad Dermatol. 1991;24:434–7
- Glade CP, Van Der Vleuten CJ, van Erp PE, et al. The epidermis of chronic idiopathic lichen planus during topical treatment with the vitamin D3 analogue KH 1060. Clin Exp Dermatol. 1998;23:14–18
- Bouloc A, Revuz J, Bagot M, et al. KH 1060 for the treatment of lichen planus: a multicenter, randomized, double-blind, vehicle-controlled study. Arch Dermatol. 2000;136:1272
- Theng CT, Tan SH, Goh CL, et al. A randomized controlled trial to compare calcipotriol with betamethasone valerate for the treatment of cutaneous lichen planus. J Dermatol Treat. 2004;15:141–5
- Omidian M, Ayoobi A, Mapar MA, et al. Efficacy of sulfasalazine in the treatment of generalized lichen planus: randomized double-blinded clinical trial on 52 patients. J Eur Acad Dermatol Venereol. 2010;24:1051–4
- Bhuiyan I, Wahab MA, Ali A, et al. Comparative efficacy of hydroxychloroquine and griseofulvin in the treatment of lichen planus. J Pak Assoc Dermatol. 2010;20:79–33
- Sehgal VN, Bikhchandani R, Koranne RV, et al. Histopathological evaluation of griseofulvin therapy in lichen planus. A double-blind controlled study. Dermatologica. 1980;161:22–7
- Sehgal VN, Abraham GJ, Malik GB. Griseofulvin therapy in lichen planus. A double-blind controlled trial. Br J Dermatol. 1972;87:383–5
- Iraji F, Faghihi G, Asilian A, et al. Comparison of the narrow band UVB versus systemic corticosteroids in the treatment of lichen planus: a randomized clinical trial. J Res Med Sci. 2011;16:1578–82
- Cribier B, Frances C, Chosidow O. Treatment of lichen planus. An evidence-based medicine analysis of efficacy. Arch Dermatol. 1998;134:1521–30
- Samycia M, Lin AN. Efficacy of topical calcineurin inhibitors in lichen planus. J Cutan Med Surg. 2012;16:221–9
- Lillevang ST, Rosenkvist J, Andersen CB, et al. Single and combined effects of the vitamin D analogue KH1060 and cyclosporin A on mercuric-chloride-induced autoimmune disease in the BN rat. Clin Exp Immunol. 1992;88:301–6
- Binderup L, Latini S, Binderup E, et al. 20-epi-vitamin D3 analogues: a novel class of potent regulators of cell growth and immune responses. Biochem Pharmacol. 1991;42:1569–75
- Veyron P, Pamphile R, Binderup L, Touraine JL. Two novel vitamin D analogues, KH 1060 and CB 966, prolong skin allograft survival in mice. Transpl Immunol. 1993;1:72–6
- Ormerod AD, Campalani E, Goodfield MJ. British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology. Br J Dermatol. 2010;162:952–63
- Bauza A, España A, Gil P, et al. Successful treatment of lichen planus with sulfasalazine in 20 patients. Int J Dermatol. 2005;44:158–62
- Massa MC, Rogers RS III. Griseofulvin therapy of lichen planus. Acta Derm Venereol. 1981;61:547–50
- Matthews RW, Scully C. Griseofulvin in the treatment of oral lichen planus: adverse drug reactions, but little beneficial effect. Ann Dent. 1992;51:10–11
- Wackernagel A, Legat FJ, Hofer A, et al. Psoralen plus UVA vs. UVB-311 nm for the treatment of lichen planus. Photodermatol Photoimmunol Photomed 2007;23:15–19
- Le Cleach L, Chosidow O. Clinical practice. Lichen planus. N Engl J Med 2012;366:723–32
- Pandhi D, Singal A, Bhattacharya SN. Lichen planus in childhood: a series of 316 patients. Pediatr Dermatol. 2014;31:59–67